Liquidia Corporation
NASDAQ: LQDA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Roger A. Jeffs
- Employees
- 170
- Headquarters
- Morrisville, United States
- IPO year
- 2018
- Market cap
- $6.3B
- Website
- https://www.liquidia.com
Loading LQDA…
Loading profile data…Frequently asked questions about LQDA
What does Liquidia Corporation (LQDA) do?
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostin...
Where does LQDA trade?
Liquidia Corporation (LQDA) trades on the NASDAQ Capital Market.
What sector is LQDA in?
Liquidia Corporation (LQDA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Liquidia Corporation?
Roger A. Jeffs is the chief executive officer of Liquidia Corporation (LQDA).
Where is Liquidia Corporation headquartered?
Liquidia Corporation is headquartered in United States.
Does LQDA pay a dividend?
Liquidia Corporation (LQDA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LQDA go public?
Liquidia Corporation (LQDA) completed its initial public offering in 2018.